Cargando…
Comment on “Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss”
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476753/ https://www.ncbi.nlm.nih.gov/pubmed/28652698 http://dx.doi.org/10.2147/OPTH.S140149 |
| _version_ | 1783244656564240384 |
|---|---|
| author | Ehrlich, Joshua R Moroi, Sayoko E |
| author_facet | Ehrlich, Joshua R Moroi, Sayoko E |
| author_sort | Ehrlich, Joshua R |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5476753 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Dove Medical Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-54767532017-06-26 Comment on “Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss” Ehrlich, Joshua R Moroi, Sayoko E Clin Ophthalmol Letter Dove Medical Press 2017-06-12 /pmc/articles/PMC5476753/ /pubmed/28652698 http://dx.doi.org/10.2147/OPTH.S140149 Text en © 2017 Ehrlich and Moroi. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
| spellingShingle | Letter Ehrlich, Joshua R Moroi, Sayoko E Comment on “Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss” |
| title | Comment on “Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss” |
| title_full | Comment on “Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss” |
| title_fullStr | Comment on “Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss” |
| title_full_unstemmed | Comment on “Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss” |
| title_short | Comment on “Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss” |
| title_sort | comment on “clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss” |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476753/ https://www.ncbi.nlm.nih.gov/pubmed/28652698 http://dx.doi.org/10.2147/OPTH.S140149 |
| work_keys_str_mv | AT ehrlichjoshuar commentonclinicaleffectivenessofcurrentlyavailablelowvisiondevicesinglaucomapatientswithmoderatetoseverevisionloss AT moroisayokoe commentonclinicaleffectivenessofcurrentlyavailablelowvisiondevicesinglaucomapatientswithmoderatetoseverevisionloss |